ACE and Alzheimer disease: Further studies have explored the unique immunomodulatory functions of myelomonocytes overexpressing ACE in the context of AD and discovered that these cells possess uniquely enhanced neuroprotective properties and an enhanced capacity to clear Aβ (Bernstein et al., 2014).